Search

everythinglearnresearchcommunity

for

Search:↓

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Some people may naturally have beaded lines on their skin that are more visible with certain treatments, and hair loss similar to post-pregnancy can occur after specific diet and therapy.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

Laser device increases hair density, safe for treating hair loss in men and women.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Certain drugs that block specific enzymes can help treat prostate diseases.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.